Tequin (gatifloxacin) is a fourth-generation antibiotic that was formerly prescribed in the US for oral use in the treatment of respiratory tract infections. It belongs to a class of popular broad-spectrum antibiotics called fluoroquinolones.
This drug has been used to treat many different bacterial infections, including pneumonia, bronchitis, sinus infections, respiratory tract infections, urinary tract infections, and certain sexually transmitted diseases. Other antibiotics in the same class include ciprofloxacin and levofloxacin.
Every year, an estimated 200,000 Americans die from adverse reactions and side effects to prescription drugs. Thousands of other Americans are seriously injured and sometimes die from adverse reactions and side effects associated with common over-the-counter medications.
Drug manufacturers pressure the Food and Drug Administration (FDA) to approve drugs quickly, before all of the data on side effects has been gathered. This “fast track” approval process generates millions of dollars for the pharmaceutical companies, at the cost of human lives.